Phathom Pharmaceuticals, Inc. revenue breakdown overview

Phathom Pharmaceuticals, Inc. revenue for the last year amounted to 55.25 M USD, the most of which — 55.25 M USD — came from its highest performing source at the moment, Vonoprazan, the year earlier bringing 682.00 k USD. The greatest contribution to the revenue figure was made by United States — last year it brought Phathom Pharmaceuticals, Inc. 55.25 M USD, and the year before that — 682.00 k USD.